Since his return, Abbott has softened the details about his educational background. Stud. Comm. Nano Reviews, 1-4 (2011), Treatment of Parkinsons disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system. [5] Some investors were concerned that the split was done to protect the value of the device business from the loss of value facing the drug division due to the imminent expiration of patents on Humira, which accounted for about half of the drug division's revenue. Named one of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005. Mr. Gonzalez, 58, was a research biochemist at the University of Miami School of Medicine and attended the University of Houston, majoring in biochemistry, according to the company's website. [41], AbbVie has been accused of using anti-competitive patent thickets to prevent potentially cheaper biosimilars from entering the market. Wyden accused the company of shifting revenue to avoid US taxes. Click here to get the full experience on your screen. More importantly the drug dose, which is usually administered by systemic administration (pills or injections) can be significantly reduced. WebRichard A. Gonzalez was born c. 1968. The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. [35] However, the first non-blinded, randomized trial found the drug not useful to treat severe COVID-19. The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. Richard L Gonzalez was born on August 16, 1967. Isomerization of n-Butane: Conversion as a Function of Sulfate Loading on Sulfated Zirconia Catalysts. Albert Gonzalez was born on 1981 in . When spun off at year-end, AbbVie will take with it Humira, the blockbuster rheumatoid arthritis drug that in 2011 reaped nearly $8 billion in sales, or about 20 percent of the $38.9 billion Abbott posted in total revenue. The shares were sold at an average price of $123.23, for a transaction totalling $21,454,343.00. On the same day, AbbVie and Calico announced that they had entered into a R&D collaboration intended to discover, develop and bring to market new therapies for patients with diseases of aging including neurodegeneration and cancer. Records show that Richard Allen Gonzalez, with a birth date consistent with Mr. Gonzalez's, attended the University of Houston from the fall of 1972 to the fall of 1973, but was not granted a degree, according to a school spokeswoman. Isomerization of n-Butane: Conversion as a Function of Sulfate Loading on Sulfated Zirconia Catalysts. Enter your email address below to get our daily insider buying and selling report. Contents 1 History 2 Acquisitions 2.1 Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. Born 1959. Ms. Brotz says Mr. Gonzalez's website bio is now correct. He is also Member of The Commercial Club of 101, 5-13 (2005). T. Lopez, Akozina, E. Ortiz-Islas, K.A.Espinosa and R.D Gonzalez. T.Lopez, J.Navarette, R.Conde, J.A.Acsencio, J.Manjarrez and R.D Gonzalez. Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and marketing medicines in more than 175 countries. Master in BioChemistry, University Miami. WebIreland. Richard also answers to Richard A Gonzalez, Richard A Gonzalez, Richard A Gonzales and Richard A Gonalez, and perhaps a couple of other names. In response, AbbVie announced that it would cease enforcing its patents on the drug entirely. There are 7 older and 24 younger executives at Abbvie Inc. B.Ch.E., Rensselaer Polytechnic Institute, 1961 M.A., The Johns Hopkins University, 1963 Ph.D., The Johns Hopkins University, 1965. Dovepress, open access to scientific and medical research 5(2010), Fractal Analysis of Tissue Biocompatible Neuroreservoirs. Pore structures in an implantable sol-gel titania ceramic device used in drug release applications: a modeling study. Mr. Gonzalez's experience and knowledge enable him to contribute to AbbVie's board key insights into strategic, management, and operational matters. Alvarez Lemus, and R.D.Gonzalez. E Kugler, Aline Auroux and RD Gonzalez. Veritas Software Corp., Kenneth Lonchar, 2002: Mr. Lonchar resigned as chief financial officer after admitting he falsely claimed to hold an MBA from Stanford University. [23][24], In May 2021, Allergan Aesthetics announced it would acquire Soliton. WebBiography Mini Bio (1) Richard A. Gonzalez is known for The Naked Gun 2: The Smell of Fear (1991). Richard A. Gonzalez has not been actively trading shares of AbbVie during the last ninety days. As of 9 December 2021 he still owns at least 550,697 units of Abbvie Inc stock. Radio Shack Corp., Dave Edmondson, 2006: Mr. Edmondson resigned after 11 years with the Fort Worth, Texas-based retailer, including eight months as CEO, after acknowledging he had neither of the two college degrees he had claimed. Patti Hart, the Yahoo director who led to search to hire Mr. Thompson, also stepped down. [47][48], In July 2022 the company agreed to pay up to $2.37 billion to settle U.S. lawsuits against its Allergan unit over the marketing of opioid painkillers. Abbvie Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. E-mail oureditor .J.Solid State Chemistry 158, 154-161 (2001). During the last year, insiders at the sold shares 11 times. It is currently caught up in a legislative battle against Icelandic Alvotech, which is trying to bring a Humira biosimilar to market. Richard Gonzalez is the chairman of the board and CEO of pharmaceutical company AbbVie. Originally an executive vice president at Abbott Laboratories, he was asked to lead AbbVie, its spinoff company, when it was launched in 2013. Leading the way is the just-signed Inflation Reduction Act of 2022. [39], As of 2019, the company remained committed to product development in the cystic fibrosis disease area, despite major success by their main competitor in the area, Vertex. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. Learn More on Richard A. Gonzalez's trading history. The corporate mailing address for Mr. Gonzalez and other AbbVie executives is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. Mr. Gonzalez's status at the University of Miami could not immediately be confirmed. In his past career Mr. Gonzalez occupied the position of President & Chief Operating Officer at Abbott Laboratories President for Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Chief Executive Officer-Operations at Abbott Laboratories President at Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), President & Senior Vice President at Hospira, Inc. and Executive Vice President at Pharmaceutical Products. Fractal Analysis of Tissue Biocompatible Neuroreservoirs. Some analysts are calling for copper to rise another 50-100%! [25] In June, Abbvie announced it would acquire TeneoOne and its lead compound TNB-383B. [27][28] In October, AbbVie announced they would acquire U.K.-based biotechnology business DJS Antibodies for $225 milion, in a deal that gives it access to an experimental drug for an aggressive lung disease as well as technology to develop certain kinds of antibody medicines. Hydrodechlorination and Partial Hydrogenation Studies over Pd-Group 1B Bimetallic Catalysts. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. As of this date, Richard is married. Abbvie Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. Email: sse@tulane.edu, The Herman and George R. Brown Professor Emeritus. Abbott Laboratories Chief Operating Officer Richard A. Gonzalez to Retire - read this article along with other careers information, tips and advice on BioSpace Over the last 10 years, insiders at Abbvie Inc have traded over $201,429,813 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 [26], In March 2022, Abbvie announced it would acquire Belgian-based Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118. Catalysis Letters, 86 (4): 151-156 (2003). My recent research interest over the last five years has been centered in the area of controlled drug release. [10], In October 2014, after a long negotiation, AbbVie stopped its efforts to acquire Shire, which would have been one of the largest M&A deals of that year and one of the largest tax inversions in history, due to changes in the US tax code by the US Treasury; AbbVie had to pay a $1.6 billion breakup fee. Learn More about Richard A. Gonzalez's net worth. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez did not receive degrees from either university. Richard A. Gonzalez is the Chairman of the Board, Chief Executive Officer of the Company. Ms. Brotz declined to say exactly when Abbott learned about the errors, except to say it was some time ago. The company corrected the information on its website immediately after the errors were discovered, she said. They sold a total of 612,950 shares worth more than $93,689,817.55. ,J.Applied Catalysis A:General 217, 143-156 (2001). [36], According to the Wall Street Journal as of January 2016 ibrutinib, a specialty drug, cost US$116,600 to $155,400 a year wholesale in the United States. Biocompatible Titania Microtubes Formed by Nanoparticles and its Application in the Drug Delivery of Valprroic Acid. Gonzalez, Richard A. was born on January 21, 1954. Chicago, IL 60601 The most recent insider tranaction occured on December, 12th when EVP Timothy J Richmond sold 42,370 shares worth more than $6,924,952.80. The board declined his offer to resign. Richard Gonzalez, named CEO of AbbVie when it is spun off from Abbott Laboratories later this year, is just the latest example of a prominent figure caught up in misstatements of educational achievements. Mr. Gonzalez earned a salary of $1,700,000.00, stock awards of $12,573,689.00, options awards of $3,134,649.00, non-equity compensation of $4,908,750.00, and other compensation of $814,073.00. Most recently he exercised 174,100 units of ABBV stock worth $10,682,776 on 9 December 2021. As the CEO of AbbVie Inc., Mr. Gonzalez earned a total compensation package of $23,912,154.00 in 2021. (Crain's) Abbott Laboratories misstated the education credentials of Richard Gonzalez, the executive tapped to head its pharmaceutical spinoff, in at least nine regulatory filings between 2002 and 2007, Crain's has found. WebRichard A Gonzalez and Richar Gonzalez are some of the alias or nicknames that Richard has used. [8] In a letter to AbbVie CEO Richard Gonzalez, Wyden noted the company suffered a 2020 pretax loss in the US of $4.5 billion and an overseas pretax profit of $7.9 billion the same year. Named one of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005. Selective Hydrogenation of Acetylene and Hydrodechlorination of 1,2-Dichloroethane over Pd-Group IB Bi-Metallic.
Bruce Bochy Head Size,
William Allen Young Kappa Alpha Psi,
Articles R